CHIEFFO, ALAIDE
 Distribuzione geografica
Continente #
NA - Nord America 8.030
AS - Asia 7.793
EU - Europa 6.811
SA - Sud America 1.658
Continente sconosciuto - Info sul continente non disponibili 708
AF - Africa 142
OC - Oceania 11
AN - Antartide 1
Totale 25.154
Nazione #
US - Stati Uniti d'America 7.587
RU - Federazione Russa 3.978
SG - Singapore 3.149
CN - Cina 2.199
BR - Brasile 1.328
HK - Hong Kong 998
IT - Italia 889
VN - Vietnam 652
SE - Svezia 418
FR - Francia 380
RO - Romania 282
DE - Germania 204
BD - Bangladesh 200
CA - Canada 185
GB - Regno Unito 167
AR - Argentina 128
IN - India 120
NL - Olanda 86
MX - Messico 84
AT - Austria 72
FI - Finlandia 70
TR - Turchia 64
EC - Ecuador 58
IQ - Iraq 56
ES - Italia 55
PL - Polonia 53
CO - Colombia 51
ID - Indonesia 49
ZA - Sudafrica 45
JM - Giamaica 43
JP - Giappone 43
CR - Costa Rica 40
IE - Irlanda 40
MY - Malesia 30
VE - Venezuela 30
PY - Paraguay 27
PK - Pakistan 25
SA - Arabia Saudita 25
MA - Marocco 22
UA - Ucraina 22
AE - Emirati Arabi Uniti 21
NP - Nepal 19
UZ - Uzbekistan 19
NI - Nicaragua 18
PH - Filippine 18
TN - Tunisia 17
CL - Cile 16
HN - Honduras 16
CH - Svizzera 14
GT - Guatemala 14
MD - Moldavia 13
LT - Lituania 12
TH - Thailandia 12
DZ - Algeria 11
IR - Iran 11
KE - Kenya 11
JO - Giordania 10
EG - Egitto 9
PE - Perù 9
BE - Belgio 8
GE - Georgia 8
SV - El Salvador 8
AU - Australia 7
AZ - Azerbaigian 7
AL - Albania 6
BB - Barbados 6
ET - Etiopia 6
GR - Grecia 6
KR - Corea 6
KZ - Kazakistan 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
HU - Ungheria 5
IL - Israele 5
KW - Kuwait 5
OM - Oman 5
PR - Porto Rico 5
RS - Serbia 5
SC - Seychelles 5
BH - Bahrain 4
BO - Bolivia 4
EE - Estonia 4
LB - Libano 4
NG - Nigeria 4
PT - Portogallo 4
AM - Armenia 3
AO - Angola 3
CY - Cipro 3
GD - Grenada 3
HR - Croazia 3
PA - Panama 3
PS - Palestinian Territory 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
HT - Haiti 2
LV - Lettonia 2
Totale 24.410
Città #
Singapore 1.468
San Jose 1.240
Dallas 1.141
Hong Kong 977
Moscow 872
Ashburn 752
Council Bluffs 493
Hefei 375
Shanghai 362
Lauterbourg 326
Ho Chi Minh City 247
Beijing 212
New York 208
Milan 201
Phoenix 200
Santa Clara 191
Lawrence 149
Princeton 149
Los Angeles 135
Hanoi 124
São Paulo 122
Rome 70
Atlanta 59
Orem 57
Nuremberg 53
Montreal 49
Chicago 48
Brooklyn 45
Helsinki 43
Munich 43
Denver 41
Chennai 40
Warsaw 38
Buffalo 37
Dublin 37
Amsterdam 35
Shenzhen 35
Tokyo 34
Boardman 33
Mexico City 33
Belo Horizonte 32
Brasília 32
San José 32
Da Nang 30
Guangzhou 30
Haiphong 30
London 30
Vienna 29
Rio de Janeiro 28
Stockholm 27
Kingston 26
Las Vegas 26
Houston 25
Johannesburg 25
Manchester 24
Seattle 24
Toronto 24
Ankara 23
Baghdad 23
Guayaquil 23
San Francisco 22
Washington 22
Boston 21
Frankfurt am Main 21
Tianjin 21
Philadelphia 19
Salvador 19
Dhaka 18
Miami 18
Xi'an 18
Newark 17
Piscataway 17
Managua 16
Mumbai 16
Poplar 16
Quito 16
Tashkent 16
Verona 16
Guarulhos 15
Kuala Lumpur 15
Bari 14
Catania 14
Hangzhou 14
Naples 14
Biên Hòa 13
Bogotá 13
Caracas 13
Charlotte 13
Florence 13
Goiânia 13
Istanbul 13
Lappeenranta 13
Manaus 13
Medellín 13
Porto Alegre 13
Turku 12
Asunción 11
Brescia 11
Cincinnati 11
Dubai 11
Totale 11.931
Nome #
European Bifurcation Club white paper on stenting techniques for patients with bifurcated coronary artery lesions 396
Prognostic impact of mitral regurgitation changes after TAVI 231
Aims and Rationale of a National Registry Integrating Clinical, Echocardiographic, and Multi-Omics Profiling to Promote Precision Medicine in Peripartum Cardiomyopathy 201
A "modified crossover technique" for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation 175
A Comparison of the Femoral and Radial Crossover Techniques for Vascular Access Management in Transcatheter Aortic Valve Implantation: The Milan Experience 170
Coronary Protection to Prevent Coronary Obstruction During TAVR 164
5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience 160
Impact on Outcome of Different Mechanisms, Baseline Degree and Changes of Mitral Regurgitation in Patients With Aortic Stenosis Who Underwent Transcatheter Aortic Valve Replacement 156
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 152
Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry 149
A comparison Of The Femoral And Radial Crossover Techniques For Vascular Access Management In Transcatheter Aortic Valve Implantation: The Milan Experience 143
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 134
Device-related complications after Impella mechanical circulatory support implantation: An IMP-IT observational multicentre registry substudy 134
A Comparison Between First-Generation and Second-Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Propensity-Matched Single-Center Experience 131
Ultrasound-assisted thrombolysis in high and intermediate-high risk pulmonary embolism patients with contraindications to systemic thrombolysis: a retrospective multicentre experience 130
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC) 127
A challenging case of transcatheter aortic prosthesis dysfunction: Endocarditis or thrombosis? 125
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations 120
A Sex-Based Analysis From the RAIN-CARDIOGROUP VII Study (VeRy Thin Stents for Patients With Left MAIn or BifurcatioN in Real Life) on Left Main Stenting 118
A systematic transoesophageal echocardiography study of suture-mediated percutaneous patent foramen ovale closure 116
17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease 114
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 114
Challenges and Opportunities for Women in Vascular Surgery: Summary from an International Roundtable Discussion 111
Corrigendum: “Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents” (The American Journal of Cardiology 118 (2016) (32–39), (S000291491630488X), (10.1016/j.amjcard.2016.04.007)) 110
A complex valve anatomy for mitraclip: Forme fruste of Barlow’s disease with cleft 110
Valve-in-valve transcatheter aortic valve implantation: The issues behind crossing a bioprosthesis 109
"Procedural trauma risks longitudinal shortening of the Promus Element™ stent platform" 108
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up 108
Observational Multicenter Registry of Patients Treated with IMPella Mechanical Circulatory Support Device in ITaly: The IMP-IT Registry 108
Impact of Left Ventricular Outflow Tract Calcification on Pacemaker Implantation After Transcatheter Aortic Valve Implantation With Second-Generation Devices 107
Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization 106
A New Tool to Manage Side-Branch Occlusion After Covered-Stent Implantation for Vascular Complications The Neocarina Reconstruction Technique 102
A novel approach to chronic total occlusions: the crosser system 102
Impact of Ascending Aorta Dilation on Mid-Term Outcome After Transcatheter Aortic Valve Implantation 100
Repeated Transcatheter Valve Interventions After Surgical Mitral Valve Replacement: A 20-Year Journey Avoiding Surgical Redo 98
A novel supra-annular plane that predicts TAVI prosthesis anchoring in raphe-type bicuspid aortic valve disease: the LIRA plane 96
Percutaneous coronary intervention for unprotected left main distal bifurcation lesions in elderly people 95
Real-Time Intravascular Ultrasound Guidance for Ultra-Low Contrast Complex Bifurcation Percutaneous Coronary Intervention 94
Impact of Left Main Calcium With Chronic Kidney Disease on Outcomes After Percutaneous Coronary Intervention for Left Main Narrowings (from the Milan and New-Tokyo Registry) 93
Impact of membranous septum length on pacemaker need with different transcatheter aortic valve replacement systems: The INTERSECT registry 93
Sex-Specific Considerations in Degenerative Aortic Stenosis for Female-Tailored Transfemoral Aortic Valve Implantation Management 91
Polymer-Free Biolimus-Eluting Stents or Polymer-Based Zotarolimus-Eluting Stents for Coronary Bifurcation Lesions 91
Coronary Artery Aneurysm Thrombosis Causing Acute Myocardial Infarction in an Adolescent With Neurofibromatosis Type 1 89
Sex and Transcatheter Aortic Valve Implantation: Impact of Female Sex on Clinical Outcomes 89
Impact of Kissing Balloon in Patients Treated With Ultrathin Stents for Left Main Lesions and Bifurcations An Analysis From the RAIN-CARDIOGROUP VII Study 87
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 87
A High Dose of Adenosine to Induce Transient Asystole for Valvuloplasty in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): Is it a Valid Alternative to Rapid Pacing? A Prospective Pilot Study 87
Ultrasound-Assisted, Catheter-Directed Thrombolysis for Acute Intermediate/High-Risk Pulmonary Embolism: Design of the Multicenter USAT IH-PE Registry and Preliminary Results 87
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents 86
Active Protection of High-Risk Small Side Branches in Bifurcation Interventions Is Preventing Occlusion Always Clinically Relevant? 83
Impact of Clinical and Lesion Features on Outcomes After Percutaneous Coronary Intervention in Bifurcation Lesions 82
Impella RP for Patients with Acute Right Ventricular Failure and Cardiogenic Shock: A Subanalysis from the IMP-IT Registry 82
Frequency of slow coronary flow following successful stent implantation and effect of Nitroprusside 82
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stentsâ Cardiogroup III Study) 82
The impact of chronic kidney disease severity on clinical outcomes after current generation drug-eluting stent implantation for left main distal bifurcation lesions: the Milan and New-Tokyo registry 81
Supra-annular sizing of transcatheter aortic valve prostheses in raphe-type bicuspid aortic valve disease: the LIRA method 81
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry 80
Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock: JACC Review Topic of the Week 79
Percutaneous treatment of acute pulmonary embolism: state of the art 79
Duration and kind of dual antiplatelet therapy for acute coronary syndrome patients: a network meta-analysis 79
Can a mechanical circulatory support comprehensive approach to cardiogenic shock at referral centers reduce 30-day mortality? 79
The feasibility of double stent strategy in left main true bifurcation with small and large angle change between diastole and systole: The Milan and New-Tokyo (MITO) registry 78
Rotational atherectomy-based percutaneous coronary intervention and the risk of contrast-induced nephropathy 78
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 78
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients â results from the BELLO (balloon elution and late loss optimization) trial 77
Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease 76
Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis SCOPE 2 Randomized Clinical Trial 75
Predictors of Advanced Conduction Disturbances Requiring a Late (≥48 H) Permanent Pacemaker Following Transcatheter Aortic Valve Replacement 75
Gender-Related Differences in Clinical Presentation and Angiographic Findings in Patients with Ischemia and No Obstructive Coronary Artery Disease (INOCA): A Single-Center Observational Registry 75
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group 74
Mortality across treatment strategies in intermediate-to-high risk pulmonary embolism in the modern era: A meta-analysis of observational studies and RCTs 74
Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction 74
Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2 73
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations 73
First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome 73
Provisional Strategy for Left Main Stem Bifurcation Disease: A State-of-the-Art Review of Technique and Outcomes 73
Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve 73
Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting Stents 73
Comparison of Incidence and Predictors of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation Using the CoreValve Versus the Edwards Valve 73
Does the STS-PROM Score or the Logistic EuroSCORE Predict Outcomes Following Transcatheter Aortic Valve Replacement at 30 Days: the Milan Experience 73
Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA Registries 72
Discrepancies in vessel sizing between angiography and intravascular ultrasound varies according to the vessel evaluated 72
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study) 72
Coronary Vasomotor Disorders: One Size Does Not Fit All 71
Impact of Post-Percutaneous Coronary Intervention Fractional Flow Reserve Measurement on Procedural Management and Clinical Outcomes: The REPEAT-FFR Study 71
Mid-term clinical outcomes after bailout drug-eluting stenting for suboptimal drug-coated balloon results: Insights from a Milan registry 71
Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: A propensity score-matched case-control study 71
Evolution, Predictors, and Neurocognitive Effects of Silent Cerebral Embolism During Transcatheter Aortic Valve Replacement 70
Angiographic analysis of pattern of late luminal loss in sirolimus- and paclitaxel-eluting stents 70
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 70
Early and mid-term results of drug-eluting stent implantation in unprotected left main 70
Impact and natural history of postprocedural aortic regurgitation on early and midterm mortality following transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis 70
Long-term outcomes following mini-crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New-Tokyo (MITO) registry 70
Interatrial Septal Tear After Patent Foramen Ovale Closure With the NobleStitch Device 70
Cardiovascular safety of assisted reproductive technology: a meta-analysis 69
Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry 69
Sex Differences in Use of Intracoronary Imaging in Patients Undergoing Percutaneous Coronary Intervention 69
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 69
The development of a Hub & Spoke network for transcatheter aortic valve replacement procedures: the operational model of the Interventional Cardiology Unit at the IRCCS San Raffaele Hospital (OSR Hub-Spoke) 69
Impact of Chronic Kidney Disease in Patients With Diabetes Mellitus after Percutaneous Coronary Intervention for Left Main Distal Bifurcation (From the Milan and New-Tokyo (MITO) Registry) 68
Totale 9.894
Categoria #
all - tutte 147.643
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.643


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202279 0 0 0 40 4 2 6 7 5 0 4 11
2022/2023964 328 170 45 5 2 83 35 46 18 10 14 208
2023/2024670 124 41 84 38 53 86 6 49 16 15 47 111
2024/20254.728 507 73 73 83 113 381 964 299 754 699 399 383
2025/202615.029 1.054 1.259 1.306 1.814 1.011 454 1.665 916 3.659 897 437 557
2026/20273.597 590 1.394 1.318 295 0 0 0 0 0 0 0 0
Totale 25.154